{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:37:05Z","timestamp":1792690625412,"version":"4.5.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T00:00:00Z","timestamp":1277424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011256","type":"journal-article","created":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T20:30:44Z","timestamp":1277497844000},"page":"e11256","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice"],"prefix":"10.1371","volume":"5","author":[{"given":"Vincent E.","family":"de Meijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna Y.","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau D.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Puder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis.","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis.","volume":"115","author":"R Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis.","volume":"371","author":"D Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites.","volume":"350","author":"P Gines","year":"2004","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0029-1192052","article-title":"Liver transplantation: the current situation.","volume":"29","author":"R Adam","year":"2009","journal-title":"Semin Liver Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-6143.2005.01143.x","article-title":"Antifibrotic agents for liver disease.","volume":"6","author":"E Albanis","year":"2006","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.","volume":"50","author":"Y Popov","year":"2009","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"G845","DOI":"10.1152\/ajpgi.2000.279.5.G845","article-title":"Fibrogenesis. V. TGF-beta signaling pathways.","volume":"279","author":"RG Wells","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.","volume":"279","author":"MJ Arthur","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","article-title":"Matrix metalloproteinases as modulators of inflammation.","volume":"19","author":"AM Manicone","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.","volume":"117","author":"JP Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families.","volume":"334","author":"F Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.","volume":"385","author":"RA Black","year":"1997","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.","volume":"385","author":"ML Moss","year":"1997","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(98)01031-X","article-title":"TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.","volume":"435","author":"A Amour","year":"1998","journal-title":"FEBS Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ng1413","article-title":"Abnormal TNF activity in Timp3-\/- mice leads to chronic hepatic inflammation and failure of liver regeneration.","volume":"36","author":"FF Mohammed","year":"2004","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/13543784.11.7.1003","article-title":"TACE inhibition: a new approach to treating inflammation.","volume":"11","author":"SA Doggrell","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ncprheum0797","article-title":"Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis.","volume":"4","author":"ML Moss","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","article-title":"Extracellular matrix degradation and the role of hepatic stellate cells.","volume":"21","author":"RC Benyon","year":"2001","journal-title":"Semin Liver Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.","volume":"46","author":"S Hemmann","year":"2007","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.21268","article-title":"Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.","volume":"44","author":"H Uchinami","year":"2006","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10409230701340019","article-title":"The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases.","volume":"42","author":"B Cauwe","year":"2007","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","article-title":"Matrix metalloproteinase proteomics: substrates, targets, and therapy.","volume":"21","author":"CJ Morrison","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2007.10.009","article-title":"Clipping, shedding and RIPping keep immunity on cue.","volume":"29","author":"G Murphy","year":"2008","journal-title":"Trends Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI19974","article-title":"Hepatoprotection via the IL-6\/Stat3 pathway.","volume":"112","author":"R Taub","year":"2003","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.","volume":"115","author":"JS Duffield","year":"2005","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.","volume":"6","author":"J Hu","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nm1101-1202","article-title":"Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.","volume":"7","author":"B Wielockx","year":"2001","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.21922","article-title":"Metalloproteinase-9 deficiency protects against hepatic ischemia\/reperfusion injury.","volume":"47","author":"T Hamada","year":"2008","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/hep.21314","article-title":"Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice.","volume":"44","author":"EW Olle","year":"2006","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An essential role for ectodomain shedding in mammalian development.","volume":"282","author":"JJ Peschon","year":"1998","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","article-title":"Regulation of matrix metalloproteinases: an overview.","volume":"253","author":"S Chakraborti","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.","volume":"92","author":"R Visse","year":"2003","journal-title":"Circ Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(96)00210-X","article-title":"Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.","volume":"74","author":"JM Clements","year":"1997","journal-title":"J Neuroimmunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI114270","article-title":"Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.","volume":"84","author":"MJ Arthur","year":"1989","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.20427","article-title":"A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.","volume":"40","author":"ST Magness","year":"2004","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/hep.1840220142","article-title":"Kupffer cell-derived 95-kd type IV collagenase\/gelatinase B: characterization and expression in cultured cells.","volume":"22","author":"PJ Winwood","year":"1995","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI200112373","article-title":"DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.","volume":"108","author":"E Olaso","year":"2001","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1053\/jhep.2000.20521","article-title":"Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.","volume":"32","author":"H Yoshiji","year":"2000","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/jhep.2002.35625","article-title":"Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.","volume":"36","author":"H Yoshiji","year":"2002","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20618","article-title":"Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration.","volume":"41","author":"FF Mohammed","year":"2005","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/0016-5085(95)90149-3","article-title":"Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor.","volume":"108","author":"MJ Czaja","year":"1995","journal-title":"Gastroenterology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10753-008-9067-1","article-title":"Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis.","volume":"31","author":"IH Bahcecioglu","year":"2008","journal-title":"Inflammation"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/taap.2001.9304","article-title":"The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride.","volume":"177","author":"PP Simeonova","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cyto.2004.11.001","article-title":"Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice.","volume":"29","author":"K Sudo","year":"2005","journal-title":"Cytokine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s004180000150","article-title":"Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.","volume":"113","author":"T Knittel","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1872-034X.2009.00541.x","article-title":"Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.","volume":"39","author":"A Kahraman","year":"2009","journal-title":"Hepatol Res"},{"key":"ref48","article-title":"Identifier: NCT01051921.","year":"2010"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/sj.bjc.6600310","article-title":"Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial.","volume":"86","author":"SR Bramhall","year":"2002","journal-title":"Br J Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-04-2252","article-title":"Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I\/II trial.","volume":"11","author":"E Rosenbaum","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations.","volume":"295","author":"LM Coussens","year":"2002","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0006-291X(92)91122-7","article-title":"Tetracyclines inhibit intracellular muscle proteolysis in vitro.","volume":"188","author":"BS Schneider","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.","volume":"354","author":"MA Moses","year":"2006","journal-title":"N Engl J Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0163-7258(97)00023-5","article-title":"Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.","volume":"75","author":"HS Rasmussen","year":"1997","journal-title":"Pharmacol Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"DE Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues.","volume":"112","author":"IS Jamall","year":"1981","journal-title":"Anal Biochem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.","volume":"43","author":"Y Popov","year":"2005","journal-title":"J Hepatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1074\/jbc.M600030200","article-title":"Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.","volume":"281","author":"Y Popov","year":"2006","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.","volume":"48","author":"Y Popov","year":"2008","journal-title":"J Hepatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:50:30Z","timestamp":1740210630000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011256"}},"subtitle":[],"editor":[{"given":"Fernando","family":"Rodrigues-Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,25]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011256","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,25]]}}}